EDRH
IMNP

Edmond de Rothschild Holding’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Edmond de Rothschild Holding’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-88,575
Closed -$16K – 789
2018
Q2 		$16K Buy
88,575
+2,250
+3% +$636 ﹤0.01% 695
2018
Q1 		$30K Buy
+86,325
New +$41.1K ﹤0.01% 677

Other funds holding IMNP

IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return

Edmond de Rothschild Holding's IMNP Position: Q3 2018 in Review

Edmond de Rothschild Holding sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2018, closing a stake of 88,575 shares — an estimated $16K sold.

Edmond de Rothschild Holding first reported a position in IMNP in Q1 2018 and held it in 2 quarters. The position peaked at $30K in Q1 2018. 1 fund tracked by Wall St. Rank holds IMNP as of Q3 2018.

  • Edmond de Rothschild Holding reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 88,575 Immune Pharmaceuticals Inc. shares in Q3 2018, an estimated $16K.
  • Edmond de Rothschild Holding first reported a position in Immune Pharmaceuticals Inc. in Q1 2018 and held it in 2 quarters.
  • Edmond de Rothschild Holding's Immune Pharmaceuticals Inc. position peaked at $30K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2018.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2018, filed 14 Nov 2018.